Evidence map›Paper›PMID 36136656›Full record

ArticleTropical medicine and infectious disease2022

Molecular Epidemiological Characterisation of ESBL- and Plasmid-Mediated AmpC-Producing

Faheema Ebrahim Choonara, Bjørg Christina Haldorsen, Jessin Janice, Joshua Mbanga, Isaac Ndhlovu, Osborne Saulosi, Tarsizio Maida, Fanuel Lampiao, Gunnar Skov Simonsen, Sabiha Yusuf Essack and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Tropical medicine and infectious disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 59% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Molecular analysis of AmpC-producing Escherichia coli isolated from pediatric patients.Journal of the Pediatric Infectious Diseases Society · 2025
    Article
  4. A nationwide survey of antimicrobial resistance ofJAC-antimicrobial resistance · 2024
    Article
  5. Antimicrobial agents and chemotherapy · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 4 countries.

Faheema Ebrahim ChoonaraAntimicrobial Research Unit, College of Health Sciences, University of KwaZulu-Natal, Private Bag X54001, Durban 4041, South Africa.
Bjørg Christina HaldorsenNorwegian National Advisory Unit on Detection of Antimicrobial Resistance (K-res), Department of Microbiology and Infection Control, University Hospital of North Norway, 9038 Tromsø, Norway.
Jessin JaniceNorwegian National Advisory Unit on Detection of Antimicrobial Resistance (K-res), Department of Microbiology and Infection Control, University Hospital of North Norway, 9038 Tromsø, Norway.ORCID 0000-0001-9991-6315
Joshua MbangaAntimicrobial Research Unit, College of Health Sciences, University of KwaZulu-Natal, Private Bag X54001, Durban 4041, South Africa.
Isaac NdhlovuMicrobiology Laboratory, Kamuzu Central Hospital, Lilongwe P.O. Box 149, Malawi.
Osborne SaulosiMicrobiology Laboratory, Kamuzu Central Hospital, Lilongwe P.O. Box 149, Malawi.
Tarsizio MaidaMicrobiology Laboratory, Kamuzu Central Hospital, Lilongwe P.O. Box 149, Malawi.
Fanuel LampiaoAfrica Centre of Excellence in Public Health and Herbal Medicine, College of Medicine, University of Malawi, Private Bag 360, Blantyre 3, Malawi.
Gunnar Skov SimonsenNorwegian National Advisory Unit on Detection of Antimicrobial Resistance (K-res), Department of Microbiology and Infection Control, University Hospital of North Norway, 9038 Tromsø, Norway.
Sabiha Yusuf EssackAntimicrobial Research Unit, College of Health Sciences, University of KwaZulu-Natal, Private Bag X54001, Durban 4041, South Africa.ORCID 0000-0003-3357-2761
Arnfinn SundsfjordNorwegian National Advisory Unit on Detection of Antimicrobial Resistance (K-res), Department of Microbiology and Infection Control, University Hospital of North Norway, 9038 Tromsø, Norway.ORCID 0000-0002-3728-2270
University Hospital of North Norway · NOKamuzu Central Hospital · MWUniversity of Malawi · MWNational University of Science and Technology · ZWUniversity of KwaZulu-Natal · ZA

Funding

Norwegian Agency for Development Cooperation under the Norwegian Program for Capacity Development in Higher Education and Research for Development (NORHED) QZA 0484 RSA 13/0010
6 · The paper itself

Abstract

The global rise in infections caused by multidrug resistant (MDR) Enterobacterales poses a public health problem. We have performed a molecular epidemiological characterisation of representative plasmid-mediated AmpC (pAmpC) and ESBL-positive clinical isolates of

Indexed as

blaCMYblaCTX-M-15clonal spreadEscherichia coliKlebsiella pneumoniae

Identifiers

PMID36136656
PMCPMC9501462
OpenAlexW4295926388

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.